199 related articles for article (PubMed ID: 10522664)
1. A systematic review of treatment modalities for primary basal cell carcinomas.
Thissen MR; Neumann MH; Schouten LJ
Arch Dermatol; 1999 Oct; 135(10):1177-83. PubMed ID: 10522664
[TBL] [Abstract][Full Text] [Related]
2. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
3. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.
Rowe DE; Carroll RJ; Day CL
J Dermatol Surg Oncol; 1989 Apr; 15(4):424-31. PubMed ID: 2925988
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rates of treated basal cell carcinomas. Part 1: Overview.
Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
J Dermatol Surg Oncol; 1991 Sep; 17(9):713-8. PubMed ID: 1890243
[TBL] [Abstract][Full Text] [Related]
5. The effective treatment of basal cell carcinoma.
Skelton LA
Br J Nurs; 2009 Mar 26-Apr 8; 18(6):346, 348-50. PubMed ID: 19329898
[TBL] [Abstract][Full Text] [Related]
6. Basal cell carcinoma: an evidence-based treatment update.
Clark CM; Furniss M; Mackay-Wiggan JM
Am J Clin Dermatol; 2014 Jul; 15(3):197-216. PubMed ID: 24733429
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma. Choosing the best method of treatment for a particular lesion.
Hacker SM; Browder JF; Ramos-Caro FA
Postgrad Med; 1993 Jun; 93(8):101-4, 106-8, 111. PubMed ID: 8506171
[TBL] [Abstract][Full Text] [Related]
9. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
10. Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma.
Zloty D; Guenther LC; Sapijaszko M; Barber K; Claveau J; Adamek T; Ashkenas J;
J Cutan Med Surg; 2015; 19(3):239-48. PubMed ID: 25986316
[TBL] [Abstract][Full Text] [Related]
11. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
J Dermatol Surg Oncol; 1991 Sep; 17(9):720-6. PubMed ID: 1820764
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Management of Basal Cell Carcinoma.
Tanese K
Curr Treat Options Oncol; 2019 Feb; 20(2):13. PubMed ID: 30741348
[TBL] [Abstract][Full Text] [Related]
13. Current modalities and new advances in the treatment of basal cell carcinoma.
Ceilley RI; Del Rosso JQ
Int J Dermatol; 2006 May; 45(5):489-98. PubMed ID: 16700779
[TBL] [Abstract][Full Text] [Related]
14. [Mohs' method of micrographic surgery as treatment for recurrent basal cell carcinoma].
van Baardwijk AA; Verhaegh ME; Krekels GA; Vermeulen AH; Neumann HA
Ned Tijdschr Geneeskd; 1997 Mar; 141(11):524-9. PubMed ID: 9190509
[TBL] [Abstract][Full Text] [Related]
15. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
16. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.
Kauvar AN; Cronin T; Roenigk R; Hruza G; Bennett R;
Dermatol Surg; 2015 May; 41(5):550-71. PubMed ID: 25868035
[TBL] [Abstract][Full Text] [Related]
17. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases.
Thissen MR; Kuijpers DI; Krekels GA
J Drugs Dermatol; 2006 May; 5(5):461-4. PubMed ID: 16703785
[TBL] [Abstract][Full Text] [Related]
18. Nonsurgical treatment options for basal cell carcinoma - focus on advanced disease.
Goldenberg G; Hamid O
J Drugs Dermatol; 2013 Dec; 12(12):1369-78. PubMed ID: 24301238
[TBL] [Abstract][Full Text] [Related]
19. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy.
Silverman MK; Kopf AW; Gladstein AH; Bart RS; Grin CM; Levenstein MJ
J Dermatol Surg Oncol; 1992 Jul; 18(7):549-54. PubMed ID: 1624628
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
Rigel DS; Torres AM; Ely H
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s15-6. PubMed ID: 18277458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
